200 related articles for article (PubMed ID: 22076550)
41. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
Lima MC; Pereira GM; Rumjanek FD; Gomes HM; Duppre N; Sampaio EP; Alvim IM; Nery JA; Sarno EN; Pessolani MC
Scand J Immunol; 2000 Apr; 51(4):419-28. PubMed ID: 10736116
[TBL] [Abstract][Full Text] [Related]
42. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
43. In vitro effect of interleukin-2 on proliferative responses of peripheral blood T cells from leprosy patients.
Choi IH; Shin JS; Kim JD; Kim SJ
Yonsei Med J; 1991 Sep; 32(3):237-42. PubMed ID: 1781183
[TBL] [Abstract][Full Text] [Related]
44. Comparative study of anti-PGL-1, anti-35 kDa and anti-lipoarabinomannan assays for serodiagnosis of leprosy.
Jayapal V; Selvibai G; Mahalakshmi K; Pushkala ; Regunath K; Subramanian S
Indian J Lepr; 2001; 73(3):229-37. PubMed ID: 11840595
[TBL] [Abstract][Full Text] [Related]
45. Field-evaluation of a new lateral flow assay for detection of cellular and humoral immunity against Mycobacterium leprae.
Bobosha K; Tjon Kon Fat EM; van den Eeden SJ; Bekele Y; van der Ploeg-van Schip JJ; de Dood CJ; Dijkman K; Franken KL; Wilson L; Aseffa A; Spencer JS; Ottenhoff TH; Corstjens PL; Geluk A
PLoS Negl Trop Dis; 2014 May; 8(5):e2845. PubMed ID: 24810599
[TBL] [Abstract][Full Text] [Related]
46. Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.
Geluk A; van der Ploeg-van Schip JJ; van Meijgaarden KE; Commandeur S; Drijfhout JW; Benckhuijsen WE; Franken KL; Naafs B; Ottenhoff TH
Clin Vaccine Immunol; 2010 Jun; 17(6):993-1004. PubMed ID: 20427628
[TBL] [Abstract][Full Text] [Related]
47. Detection of M. leprae-specific antigens with dot-ELISA in urine and nasal samples from leprosy patients.
Singh NB; Choudhary A; Bhatnagar S
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):398-404. PubMed ID: 1890363
[TBL] [Abstract][Full Text] [Related]
48. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
[TBL] [Abstract][Full Text] [Related]
49. Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls.
Ilangumaran S; Shanker Narayan NP; Ramu G; Muthukkaruppan VR
Clin Exp Immunol; 1994 Apr; 96(1):79-85. PubMed ID: 8149671
[TBL] [Abstract][Full Text] [Related]
50. Fate of T Cells and their Secretory Proteins During the Progression of Leprosy.
Tarique M; Saini C; Naz H; Naqvi RA; Khan FI; Sharma A
Curr Protein Pept Sci; 2018; 19(9):889-899. PubMed ID: 28847289
[TBL] [Abstract][Full Text] [Related]
51. Prospective immunological follow-up in household contacts of Mexican leprosy patients.
Amezcua ME; Escobar-Gutiérrez A; Barba-Rubio J; Cázares JV; Mayén E; Chávez-Núñez M; Peña RC; Rodríguez R; Pastén S
Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):651-9. PubMed ID: 2280115
[TBL] [Abstract][Full Text] [Related]
52. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
53. Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.
Kaplan G; Sampaio EP; Walsh GP; Burkhardt RA; Fajardo TT; Guido LS; de Miranda Machado A; Cellona RV; Abalos RM; Sarno EN
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6269-73. PubMed ID: 2668961
[TBL] [Abstract][Full Text] [Related]
54. Demonstration of mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique.
Mshana RN; Humber DP; Harboe M; Belehu A
Clin Immunol Immunopathol; 1983 Dec; 29(3):359-68. PubMed ID: 6416726
[TBL] [Abstract][Full Text] [Related]
55. A method for the detection of M. leprae antigens in urine of leprosy patients by gel diffusion and gel electrophoretic techniques and significance in diagnosis.
Patil SA; Katoch K; Sengupta U
Acta Leprol; 1991; 7(5):403-7. PubMed ID: 1805496
[TBL] [Abstract][Full Text] [Related]
56. Immunological responsiveness to M. leprae and BCG antigens in 98 leprosy patients and their household contacts.
Sarno EN; Espinosa M; Sampaio EP; Vieira LM; Figueiredo AA; Miranda CF; Esquenazi D; Salgado JL; Nogueira N
Braz J Med Biol Res; 1988; 21(3):461-70. PubMed ID: 3147795
[TBL] [Abstract][Full Text] [Related]
57. Associations between HLA-DRB1 alleles and leprosy in an Indonesian population.
Soebono H; Giphart MJ; Schreuder GM; Klatser PR; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):190-6. PubMed ID: 9251590
[TBL] [Abstract][Full Text] [Related]
58. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
[TBL] [Abstract][Full Text] [Related]
59. IL-10 production from dendritic cells is associated with DC SIGN in human leprosy.
Kumar S; Naqvi RA; Bhat AA; Rani R; Ali R; Agnihotri A; Khanna N; Rao DN
Immunobiology; 2013 Dec; 218(12):1488-96. PubMed ID: 23816300
[TBL] [Abstract][Full Text] [Related]
60. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
